Moleculin Biotech, Inc. (MBRX) (CIK 0001659617) (MBRX)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Apr. 10, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 10, 2026 | CORRESP | Neutral/Informational | Moderate | Moleculin Biotech, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, which was filed on March 27, 2026. They ar… | Read Filing EDGAR |
| Apr. 2, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Moleculin Biotech, Inc. that it will not review their registration statement filed on March 27, 2026. The letter emphasizes the company's responsibilit… | Read Filing EDGAR |
| Jan. 2, 2026 | CORRESP | Neutral/Informational | Moderate | Moleculin Biotech, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be declared eff… | Read Filing EDGAR |
| Jan. 2, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Moleculin Biotech, Inc. that it will not review their registration statement filed on December 23, 2025. The letter emphasizes the company's responsibi… | Read Filing EDGAR |